TCTC Holdings LLC bought a new stake in shares of Marsh & McLennan Companies, Inc. (NYSE:MRSH – Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 7,247 shares of the financial services provider’s stock, valued at approximately $1,344,000.
A number of other hedge funds have also added to or reduced their stakes in the business. KERR FINANCIAL PLANNING Corp bought a new stake in shares of Marsh & McLennan Companies in the 4th quarter valued at $27,000. City Holding Co. acquired a new stake in Marsh & McLennan Companies in the fourth quarter worth $29,000. Headlands Technologies LLC bought a new stake in Marsh & McLennan Companies in the second quarter valued at $29,000. Financial Life Planners bought a new position in shares of Marsh & McLennan Companies during the 3rd quarter worth about $32,000. Finally, Elyxium Wealth LLC acquired a new stake in shares of Marsh & McLennan Companies in the 4th quarter valued at about $34,000. 87.99% of the stock is currently owned by institutional investors.
Marsh & McLennan Companies Stock Up 0.6%
Shares of NYSE:MRSH opened at $168.20 on Friday. The company has a market cap of $81.26 billion, a P/E ratio of 21.02, a P/E/G ratio of 2.43 and a beta of 0.62. Marsh & McLennan Companies, Inc. has a 12-month low of $156.60 and a 12-month high of $220.32. The company has a debt-to-equity ratio of 1.28, a quick ratio of 1.11 and a current ratio of 1.11.
Analysts Set New Price Targets
Several brokerages have issued reports on MRSH. Citigroup upgraded Marsh & McLennan Companies from a “neutral” rating to a “buy” rating and set a $200.00 price target on the stock in a report on Wednesday, May 6th. Wells Fargo & Company lowered their target price on Marsh & McLennan Companies from $203.00 to $178.00 and set an “equal weight” rating on the stock in a research report on Thursday, April 9th. Barclays reduced their price target on shares of Marsh & McLennan Companies from $209.00 to $206.00 and set an “overweight” rating for the company in a research report on Wednesday, April 8th. Bank of America lowered their price objective on shares of Marsh & McLennan Companies from $181.00 to $174.00 and set an “underperform” rating on the stock in a report on Tuesday, April 14th. Finally, Keefe, Bruyette & Woods lifted their price objective on shares of Marsh & McLennan Companies from $200.00 to $203.00 and gave the company a “market perform” rating in a report on Friday, April 17th. One research analyst has rated the stock with a Strong Buy rating, six have given a Buy rating, ten have issued a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average target price of $200.19.
Get Our Latest Stock Analysis on MRSH
Insiders Place Their Bets
In related news, CEO John Q. Doyle sold 16,656 shares of the business’s stock in a transaction dated Tuesday, June 2nd. The shares were sold at an average price of $161.71, for a total transaction of $2,693,441.76. Following the transaction, the chief executive officer directly owned 116,811 shares in the company, valued at approximately $18,889,506.81. The trade was a 12.48% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Company insiders own 0.38% of the company’s stock.
Marsh & McLennan Companies Company Profile
Marsh & McLennan Companies (NYSE: MMC) is a global professional services firm headquartered in New York City that provides advice and solutions in the areas of risk, strategy and people. Founded in 1905, the company has grown into a diversified group of businesses focused on insurance brokerage and risk management, reinsurance, human capital and investment consulting, and management consulting. Its long history and scale position it as a prominent adviser to corporations, governments and other institutions seeking to manage risk and optimize human and financial capital.
The firm operates through several well-known subsidiaries and business units that specialize in distinct services.
Recommended Stories
- Five stocks we like better than Marsh & McLennan Companies
- Microsoft Just Gave Investors 3 Dates They Can’t Afford to Ignore
- NVIDIA’s Outlook Gains Momentum: Stock Price to Follow
- The World Cup Is Coming—These 3 Stocks Could Cash In
- Spotify’s “North Star” Outlook Was Music to Investors Ears
Want to see what other hedge funds are holding MRSH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Marsh & McLennan Companies, Inc. (NYSE:MRSH – Free Report).
Receive News & Ratings for Marsh & McLennan Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Marsh & McLennan Companies and related companies with MarketBeat.com's FREE daily email newsletter.
